401 related articles for article (PubMed ID: 33585240)
21. 20(S)-ginsenoside-Rg3 reverses temozolomide resistance and restrains epithelial-mesenchymal transition progression in glioblastoma.
Chen Z; Wei X; Shen L; Zhu H; Zheng X
Cancer Sci; 2019 Jan; 110(1):389-400. PubMed ID: 30431207
[TBL] [Abstract][Full Text] [Related]
22. Identification of GSK3β inhibitor kenpaullone as a temozolomide enhancer against glioblastoma.
Kitabayashi T; Dong Y; Furuta T; Sabit H; Jiapaer S; Zhang J; Zhang G; Hayashi Y; Kobayashi M; Domoto T; Minamoto T; Hirao A; Nakada M
Sci Rep; 2019 Jul; 9(1):10049. PubMed ID: 31296906
[TBL] [Abstract][Full Text] [Related]
23. Brain-Mimetic 3D Culture Platforms Allow Investigation of Cooperative Effects of Extracellular Matrix Features on Therapeutic Resistance in Glioblastoma.
Xiao W; Zhang R; Sohrabi A; Ehsanipour A; Sun S; Liang J; Walthers CM; Ta L; Nathanson DA; Seidlits SK
Cancer Res; 2018 Mar; 78(5):1358-1370. PubMed ID: 29282221
[TBL] [Abstract][Full Text] [Related]
24. The efficacy of a coordinated pharmacological blockade in glioblastoma stem cells with nine repurposed drugs using the CUSP9 strategy.
Skaga E; Skaga IØ; Grieg Z; Sandberg CJ; Langmoen IA; Vik-Mo EO
J Cancer Res Clin Oncol; 2019 Jun; 145(6):1495-1507. PubMed ID: 31028540
[TBL] [Abstract][Full Text] [Related]
25. Rapid and Efficient Invasion Assay of Glioblastoma in Human Brain Organoids.
Goranci-Buzhala G; Mariappan A; Gabriel E; Ramani A; Ricci-Vitiani L; Buccarelli M; D'Alessandris QG; Pallini R; Gopalakrishnan J
Cell Rep; 2020 Jun; 31(10):107738. PubMed ID: 32521263
[TBL] [Abstract][Full Text] [Related]
26. Glioblastoma modeling with 3D organoids: progress and challenges.
Wang X; Sun Y; Zhang DY; Ming GL; Song H
Oxf Open Neurosci; 2023; 2():kvad008. PubMed ID: 38596241
[TBL] [Abstract][Full Text] [Related]
27. Combined effects of niclosamide and temozolomide against human glioblastoma tumorspheres.
Oh HC; Shim JK; Park J; Lee JH; Choi RJ; Kim NH; Kim HS; Moon JH; Kim EH; Chang JH; Yook JI; Kang SG
J Cancer Res Clin Oncol; 2020 Nov; 146(11):2817-2828. PubMed ID: 32712753
[TBL] [Abstract][Full Text] [Related]
28. Immunotherapy targeting glioma stem cells--insights and perspectives.
Li Z; Lee JW; Mukherjee D; Ji J; Jeswani SP; Black KL; Yu JS
Expert Opin Biol Ther; 2012 Feb; 12(2):165-78. PubMed ID: 22200324
[TBL] [Abstract][Full Text] [Related]
29. Divergent evolution of temozolomide resistance in glioblastoma stem cells is reflected in extracellular vesicles and coupled with radiosensitization.
Garnier D; Meehan B; Kislinger T; Daniel P; Sinha A; Abdulkarim B; Nakano I; Rak J
Neuro Oncol; 2018 Jan; 20(2):236-248. PubMed ID: 29016925
[TBL] [Abstract][Full Text] [Related]
30. Mechanisms and Antitumor Activity of a Binary EGFR/DNA-Targeting Strategy Overcomes Resistance of Glioblastoma Stem Cells to Temozolomide.
Sharifi Z; Abdulkarim B; Meehan B; Rak J; Daniel P; Schmitt J; Lauzon N; Eppert K; Duncan HM; Petrecca K; Guiot MC; Jean-Claude B; Sabri S
Clin Cancer Res; 2019 Dec; 25(24):7594-7608. PubMed ID: 31540977
[TBL] [Abstract][Full Text] [Related]
31. 3D-Bioprinted Mini-Brain: A Glioblastoma Model to Study Cellular Interactions and Therapeutics.
Heinrich MA; Bansal R; Lammers T; Zhang YS; Michel Schiffelers R; Prakash J
Adv Mater; 2019 Apr; 31(14):e1806590. PubMed ID: 30702785
[TBL] [Abstract][Full Text] [Related]
32. Tumor microenvironment tenascin-C promotes glioblastoma invasion and negatively regulates tumor proliferation.
Xia S; Lal B; Tung B; Wang S; Goodwin CR; Laterra J
Neuro Oncol; 2016 Apr; 18(4):507-17. PubMed ID: 26320116
[TBL] [Abstract][Full Text] [Related]
33. Biomimetic models to examine microenvironmental regulation of glioblastoma stem cells.
Nakod PS; Kim Y; Rao SS
Cancer Lett; 2018 Aug; 429():41-53. PubMed ID: 29746930
[TBL] [Abstract][Full Text] [Related]
34. Gene signatures of quiescent glioblastoma cells reveal mesenchymal shift and interactions with niche microenvironment.
Tejero R; Huang Y; Katsyv I; Kluge M; Lin JY; Tome-Garcia J; Daviaud N; Wang Y; Zhang B; Tsankova NM; Friedel CC; Zou H; Friedel RH
EBioMedicine; 2019 Apr; 42():252-269. PubMed ID: 30952620
[TBL] [Abstract][Full Text] [Related]
35. Engagement of cellular prion protein with the co-chaperone Hsp70/90 organizing protein regulates the proliferation of glioblastoma stem-like cells.
Iglesia RP; Prado MB; Cruz L; Martins VR; Santos TG; Lopes MH
Stem Cell Res Ther; 2017 Apr; 8(1):76. PubMed ID: 28412969
[TBL] [Abstract][Full Text] [Related]
36. Engineering Three-Dimensional Tumor Models to Study Glioma Cancer Stem Cells and Tumor Microenvironment.
Ruiz-Garcia H; Alvarado-Estrada K; Schiapparelli P; Quinones-Hinojosa A; Trifiletti DM
Front Cell Neurosci; 2020; 14():558381. PubMed ID: 33177991
[TBL] [Abstract][Full Text] [Related]
37. Indoleamine 2,3-dioxygenase 1 is highly expressed in glioma stem cells.
Ozawa Y; Yamamuro S; Sano E; Tatsuoka J; Hanashima Y; Yoshimura S; Sumi K; Hara H; Nakayama T; Suzuki Y; Yoshino A
Biochem Biophys Res Commun; 2020 Apr; 524(3):723-729. PubMed ID: 32035622
[TBL] [Abstract][Full Text] [Related]
38. Standardized orthotopic xenografts in zebrafish reveal glioma cell-line-specific characteristics and tumor cell heterogeneity.
Welker AM; Jaros BD; Puduvalli VK; Imitola J; Kaur B; Beattie CE
Dis Model Mech; 2016 Feb; 9(2):199-210. PubMed ID: 26659251
[TBL] [Abstract][Full Text] [Related]
39. Novel N-cadherin antagonist causes glioblastoma cell death in a 3D bioprinted co-culture model.
Smits IPM; Blaschuk OW; Willerth SM
Biochem Biophys Res Commun; 2020 Aug; 529(2):162-168. PubMed ID: 32703405
[TBL] [Abstract][Full Text] [Related]
40. Isolation and Characterization of Fast-Migrating Human Glioma Cells in the Progression of Malignant Gliomas.
Adamski V; Schmitt AD; Flüh C; Synowitz M; Hattermann K; Held-Feindt J
Oncol Res; 2017 Mar; 25(3):341-353. PubMed ID: 27641619
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
